The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples

<div>Contribution to variance explained by metabolic syndrome (MetS) and other included covariates. (a) Variance explained by including MetS (<i>x</i>-axis). (b) Variance explained by including MetS components. The proteins are color coded according to ICC, that is, proportion of interindividual variance to total variance. Proteins with high ICC vary less within and more between participants, whereas proteins with low ICC vary less between and more within participants. Proteins in black were significantly associated with MetS or any MetS component.</div>

Mediators of Inflammation

fig3

Figure 3

Figure 3: The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples 

Figure 3 | The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples 